CMMI Announces Flexibilities to the Oncology Care Model During COVID-19 Pandemic

June 4, 2020

The Centers for Medicare & Medicaid Services Innovation Center (CMMI) announced new flexibilities and adjustments to its current and future alternative payment models in response to the COVID-19 Public Health Emergency (PHE).

Of note for the cancer community, CMMI made the following changes to the Oncology Care Model:

  • Payment Methodology
    • Option for OCM practices to elect to forgo upside and downside risk for performance periods affected by the PHE
    • For OCM practices that remain in one- or two-sided risk for the performance periods affected by the PHE, remove COVID-19 episodes from reconciliation for those performance periods
  • Quality Reporting
    • Make the following optional for the affected performance periods:
      • Aggregate-level reporting of quality measures
      • Beneficiary-level reporting of clinical and staging data
    • Remove the requirement for cost and resource utilization reporting and practice transformation plan reporting in July/August 2020
  • Timeline
    • Extend model for 1 year through June 2022                                

For more information: CMMI will host a call on Friday, June 5, 2020 from 2:00PM – 3:00PM ET to provide an overview of the Oncology Care Model adjustments and flexibilities and answer any questions. Register here.

Stay up to date on the latest cancer policy and practice news through ASCO in Action.